Universal WBC reduction: the case for and against - PubMed (original) (raw)
Review
Universal WBC reduction: the case for and against
E C Vamvakas et al. Transfusion. 2001 May.
No abstract available
Comment in
- Universal WBC reduction.
Borzini P. Borzini P. Transfusion. 2001 Nov;41(11):1456. doi: 10.1046/j.1537-2995.2001.41111456.x. Transfusion. 2001. PMID: 11724998 No abstract available.
Similar articles
- Universal leukocyte reduction: Is it appropriate medical practice or not?
Angelbeck JH, Ortolano GA. Angelbeck JH, et al. J Infus Nurs. 2005 Jul-Aug;28(4):273-81. doi: 10.1097/00129804-200507000-00010. J Infus Nurs. 2005. PMID: 16106211 Review. - Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement.
Laupacis A, Brown J, Costello B, Delage G, Freedman J, Hume H, King S, Kleinman S, Mazzulli T, Wells G. Laupacis A, et al. Transfusion. 2001 Apr;41(4):560-9. doi: 10.1046/j.1537-2995.2001.41040560.x. Transfusion. 2001. PMID: 11316911 Review. No abstract available. - Canadian Red Cross Society symposium on leukodepletion: report of proceedings.
Freedman JJ, Blajchman MA, McCombie N. Freedman JJ, et al. Transfus Med Rev. 1994 Jan;8(1):1-14. doi: 10.1016/s0887-7963(94)70093-6. Transfus Med Rev. 1994. PMID: 7907899 No abstract available. - Pulmonary dysfunction during one-lung ventilation caused by HLA-specific antibodies against leukocytes.
De Wolf AM, Van den Berg BW, Hoffman HJ, Van Zundert AA. De Wolf AM, et al. Anesth Analg. 1987 May;66(5):463-7. doi: 10.1213/00000539-198705000-00018. Anesth Analg. 1987. PMID: 3578855 No abstract available. - Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction.
Blajchman MA, Goldman M, Freedman JJ, Sher GD. Blajchman MA, et al. Transfus Med Rev. 2001 Jan;15(1):1-20. doi: 10.1053/tmrv.2001.19946. Transfus Med Rev. 2001. PMID: 11149975 Review. No abstract available.
Cited by
- Delayed gastric emptying in critical illness: is enhanced enterogastric inhibition with cholecystokinin and peptide YY involved?
Samis AJ. Samis AJ. Crit Care Med. 2008 May;36(5):1655-6. doi: 10.1097/CCM.0b013e318170157b. Crit Care Med. 2008. PMID: 18448925 Free PMC article. No abstract available. - Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.
Vamvakas EC, Blajchman MA. Vamvakas EC, et al. Transfus Med Rev. 2010 Apr;24(2):77-124. doi: 10.1016/j.tmrv.2009.11.001. Transfus Med Rev. 2010. PMID: 20303034 Free PMC article. Review. - Infectious and immunologic consequences of blood transfusion.
Dellinger EP, Anaya DA. Dellinger EP, et al. Crit Care. 2004;8 Suppl 2(Suppl 2):S18-23. doi: 10.1186/cc2847. Epub 2004 Jun 14. Crit Care. 2004. PMID: 15196317 Free PMC article. Review. - Nineteen years of experience with autotransfusion for elective surgery in children: more troublesome than we expected.
Tasaki T, Ohto H. Tasaki T, et al. Transfusion. 2007 Aug;47(8):1503-9. doi: 10.1111/j.1537-2995.2007.01290.x. Transfusion. 2007. PMID: 17655595 Free PMC article. - Using basic ethical principles to evaluate safety efforts in transfusion medicine.
Brooks JP. Brooks JP. J Blood Transfus. 2012;2012:407326. doi: 10.1155/2012/407326. Epub 2011 Dec 7. J Blood Transfus. 2012. PMID: 24089647 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical